1. I N N O VAT I O N T O D AY | 4 74 6 | I N N O VAT I O N T O D AY
UK AND GLOBAL MENTAL HEALTH
In the UK, mental health conditions cost the UK economy
£105bn and it is suggested those with severe conditions
may have 15-20 years shorter life expectancy. There is a
lack of enough money, Doctors, Psychological Therapists
and time for quality human interaction in mental health
provision. A ‘Parity of Esteem’ pledge was made in 2014 yet
UK media carries frequent health stories about individuals
in distress - all need caring human contact and social
interaction for health and wellbeing. Recent NHS England
statistics reveal that of the 1 in 4 people1 who experience
mental health problems each year , 75% receive no help
despite the NHS spending £9.2bn per year. With a growing
number of ‘online supports’ being offered to patients with
mental health conditions, technology does not always
provide a best solution. It is suggested that up to 70% of
GP appointments are stress related conditions. Despite
increasing investment where NHS Patients receive talking
therapy , there are still areas in the country where patients
wait more than 4 months to receive CBT - Cognitive
Behavioural Technique. The NHS IAPT programme uses
CBT as it is a NICE evidence based psychological therapy
intervention to offer NHS patients. There are a growing
number of mental health professionals ‘speaking out’ who
do not believe that CBT is always effective.
Mental health is a global issue and of growing public health
concern. Poor mental health and lack of any appropriate
provision can exacerbate anxiety, depression and long term
conditions. Depression (major depressive disorder or clinical
depression) is a common but serious mood disorder as it
causes severe symptoms that affect how you feel, think, and
handle daily activities, such as sleeping, eating, or working.
Also called major depressive disorder or clinical depression,
it affects how you feel, think and behave and can lead to a
variety of emotional and physical problems.
In March, I was delighted to be asked to write the very first White Paper for Innovation Today. In 1997, I invented the Colour
Breathing Disks©
, which has evolved into a mental health and technology innovation. Nineteen years of research and
development has created a psychological therapy system with related products to improve patient access to behavioural
health. Wellbeing and prevention programmes will soon have the ability to deliver practical and effective CBRT™ (Colour
Breathing Relaxation Technique©
) Relaxation Support Sessions - which being structured - can demonstrate ‘measurable
outcomes’ and also provide users with a tool kit for use at home. The full UK Patent “Apparatus for Use in Colour Breathing”
was granted in 2000. CBRT™ also successfully completed the NHS National Innovation Centre Technology Scorecard Process
in 2012 (score 92.53%.)
Martin Fish, Director of Innovation Today also introduced me to Titanium Capital PTE Ltd. I am therefore delighted that the
offer of 70% funding for an initial £10 million Titanium Capital CBRT™ Programme for global research and company expansion
has been made. It is anticipated that CBRT™ will quickly become a global billion dollar business as Titanium Capital are active
in 61 countries with a wide management network infrastructure. CBRT™ HIS Ltd is now due to release ≤30% equity upon
completion of a professional IPR valuation. Please contact CBRT Healthcare Innovation Systems Ltd directly if this investment
opportunity is of interest to you.
By Alison Bourne
COLOUR BREATHING RELAXATION TECHNOLOGY
The World Health Organisation projects the global cost of
depression will be £30T by 2030. Mental health conditions
impact individuals, their families, local communities and the
national socio-economic landscapes. A recent study by the
California Mental Health Services Authority (CalMHSA) used
social marketing to reduce the stigma and discrimination
associated with mental illness. They found evidence that
their campaign efforts to reach California residents in
psychological distress were successful and 120,000 residents
may have received services as a result of exposure to their
mental health education campaigns. The social media action
helped people to not feel inferior or flawed about having a
mental health condition and to ‘take positive action.’
CBRT™ (COLOUR BREATHING RELAXATION TECHNIQUE) IS
A FIRST TIER MENTAL HEALTH PREVENTION STRATEGY AND
RELAXATION SUPPORT INTERVENTION FOR ALL MENTAL
HEALTH PROGRAMMES
The Colour Breathing Disks® were first created to promote
natural relaxation in a book kit form, with Audio and Music
CDS and a set of Affirmation Cards. Initial trials with 125
members of the public prior to publication 1998 - 2000
found that looking at the colour breathing Disks was found
easier and more effective than creative visualisation.
CBRT™ further evolved with a two day Practitioner Training
Programme recognised by the BCMA in 2004. To date,
CBRT™ has been used in the UK to support local community
based initiatives for stigma and discrimination reduction,
suicide prevention, life after cancer and student mental
health. Positive users feedback from recent usage in
Northern Ireland continues to demonstrate how CBRT™
provides valuable support in recovery and rehabilitation
programmes.
CBRT™ IS A DISRUPTIVE INNOVATION FOR POSITIVE
CHANGE
CBRT™ is working to improve mental health
outcomes for individuals, families, and communities
through having CBRT™ Practitioners available in
communities - creating an accessible national
grassroots ‘support team’ and network of CBRT™
Relaxation Support Sessions. It has the potential to
transform mainstream mental health provision and
health prevention programmes and provide effective,
low cost therapy treatments for patients experiencing
anxiety, depression and long term conditions.
An easy to learn technique, CBRT™ can deliver
measurable outcomes as part of clinician led mental
health and wellbeing programmes. More importantly
- being straightforward and easy to use, people appear
to enjoy using the tools .
CBRT™ IS STARTING TO BECOME NHS EVIDENCE BASED
CBRT™ RSS will soon be delivered and evaluated
within a community primary care general practice
setting by an NHS General Mental Health Practitioner
with 25 years experience. The clinical lead has
completed the CBRT™ Training Programme,
assessment paper and case studies. He estimates that
“at least 80% of his known Patients will have already
experienced CBT” and of these NHS Patients “most
have only found a ‘minimal to moderate’ improvement
and are still facing ‘major’ mental health issues.”
Of the NHS patients on record, it is estimated that only
20% have found any form of ‘long term remission’
from their difficulties through using CBT.
It is anticipated that many of the trial group
participants will not have experienced Colour Breathing
or mindfulness based practices before. Each Patient
will receive between 4 to 8 individual ‘One to One’
sessions as part of their treatment, with possibility
of future inclusion of small CBRT™ group sessions
(> 5 patients) for ongoing support. CORE –OM* is
a known system of choice for routine outcomes
measurement in psychological therapies in the UK
and helps fulfil NHS IAPT KPIs* and data standards and
requirements and CORE 34 will be used as the Patient
outcome measure. It will gauge the effectiveness of
the treatment in terms of the way it was viewed by
the participants and also whether their mental health
conditions or sense of well-being has been improved.
The premise is that this innovation, in which the
application of colour is part of the clinical practice, will
provide Patients with a new mental health intervention
for long term support and create the first NHS
evidence base.
USE OF ANTIDEPRESSANTS
The UK now has the seventh highest prescribing rate
for antidepressants in the Western world, with around
four million Britons taking them each year.
The Quality Watch report “Focus On: Antidepressant
prescribing Trends in the prescribing of antidepressants
in primary care” provides detailed analysis of this trend.
In 2014: i) There were 53 million prescriptions - twice
as many as a decade ago; ii) The Health and Social
Care Information Centre found NHS spending on
anti-depressants had risen by 33.6 per cent since the
previous year, to £282 million.
NHS guidance says anti-depressants should not
be offered as the first resort for people with mild
to moderate depression, and that such cases
should instead be referred for “talking therapy” such
as cognitive behavioural therapy. The Telegraph
newspaper reported “Staggering rise in prescribing of
anti-depressants” mentioning mental health charities
‘concerned that people suffering from depression
were being given drugs because other help – such as
counselling, which was sometimes more appropriate
– was not available.’
WHY IS HEALTHCARE AND INNOVATION TREATED SO
DIFFERENTLY IN THE USA?
In the USA, the consumer population spends
$38 billion USD a year on CAM (Complementary
Alternative Medicine) with a growing use of yoga and
meditation for ‘self help’ and wellbeing. It is estimated
that over 50 million USA population have an interest
in having a holistic and ‘mind-body-spirit’ approach to
health. The USA health press often feels 20 to 30 years
ahead of the UK as the benefits of ‘quantum healing’
and ‘energy psychology’ are discussed. Providers of
holistic practice also have additional business support
via a state-wide “Holistic Chambers of Commerce.”
Investment in technology innovation is also different
in the USA where failure and ‘mistakes’ made along the
way by entrepreneurs. There is also far more support
for ‘blue sky’ thinking – surely this is what innovation
is all about? A recent start-up called ‘Shyp’ raised a
whopping $63 million USD during its start-up phase.
INNOVATION FUNDING SUPPORT NEEDS TO CHANGE - AS
A LONE INVENTOR YOU HAVE TO FUND EVERYTHING
CBRT™ has experienced how public innovation
funding can bias towards its own people and ‘not for
profits’ - many already receiving grant funding from
charitable foundations and EU programmes. The
‘small print’ prevents private innovation which has a
limited budget. UK Angel investment networks with
whom contact has been made - feel that ‘mental
health is a matter for the NHS to solve.’ UK investment
networks currently seem to focus in technology
start-ups, genetics, bioscience, digital/APPs and
telemedicine - especially where there are incentives
e.g. working with universities and the NHS.

2. 4 8 | I N N O VAT I O N T O D AY
Many grants can only be applied for if there is
collaboration with academic groups or universities
– both already funded by the public. At last, with the
investment programme – CBRT™ will be able to apply
for an ‘Innovate UK’ grant – as this grant requires the
ability to provide a form of matched funding.
CBRT™ HAS CREATED A ‘LEADING EDGE’ RELAXATION
INTERVENTION AND COMPACT PSYCHOLOGICAL THERAPY
WHICH IS USER-FRIENDLY
During 19 years there have been many meetings with
people who have the word ‘innovation’ in their titles.
The words ‘innovation’ and innovator are sometimes
used freely by people who have never actually
invented anything, often protected in a well paid
day job, highly privileged positions. Sheltered from
the risks of innovation, they often fail to appreciate
how ‘time is of the essence’ in the private sector.
With lifestyle costs covered (salary, pension, holiday
pay) and innovation outgoings (offices, equipment,
meetings, cars, travel, conference costs/ overnight
stays, time to research, writing grant applications)
being ‘there to use’ – it is no wonder there is a total
disparity with private innovation .
A TECHNOLOGY WHICH USES COLOUR SCIENCE
CBRT™ was recently invited to present at the PICS
2016 conference at UCL London with an Abstract
paper written about the forthcoming CBRT™ NHS pilot
study.
Research indicates how >70% of the population
are visual learners. CBRT™ is based on a set of seven
compelling/radiant “Colour Breathing Disks©
, each with
a unique gradient design - as the primary focus - whilst
users become aware of how their physical body feels
and breathing pattern. Colour Breathing provides a
unique form of visual mindfulness, using pure colour
as presented in the Colour Breathing Disks® for the
focus in relaxation, awareness of the physical body and
correct breathing whilst using affirmations (positive
psychology) in the ‘present moment.’ The Colour
Breathing Disks©
system provides an easy to follow
gradual body relaxation.
The Colour Breathing Disks©
are seven circles of
pure colour (red, orange, yellow, green, blue, purple
and magenta) each with a distinctive varying gradient
design. They are each presented in individual
settings on a white background in the order of
(R, O, Y, G, B, P, M) in an easel card, ‘stand alone’
format, with a wire-o-bind attachment mechanism,
which enables each CB Disk to be viewed and changed
in the correct sequence during the relaxation session.
Each colour relates to a different areas of the body -
the base of spine, pelvic area, stomach, heart/lungs,
throat, forehead and crown areas.
CBRT™ also uses positive affirmations - there are
currently 70 CBRT™ Affirmation Cards used during the
relaxation process. The user selects which Affirmation
cards they wish to use with each Colour Breathing
Disk©
as part of the process. Professionals have found
that users feel more engaged and involved in their
relaxation session.
The CBRT™ Initial Response Sheets (IRS) created over
7 years have been found to encourage open dialogue
and free communication between the practitioner
and the user. Part of the unique CBRT™ relaxation
‘experience’ for individual users is completion of the
CBRT™ IRS with their Practitioner before their first
and last CBRT™ RSS. IRS form the foundation of how
CBRT™ can be used as a ‘Talking Therapy.’ Patients
often learn new self care skills and feel self empowered
after sessions.
Colours can have a strong emotional or visceral effect
and can affect our psychological state.
There is also increasing evidence that colour can
I N N O VAT I O N T O D AY | 4 9
impact upon health and well-being. The use of light
to treat depression and seasonal affective disorder
is well established. There is evidence that light of
particular colour can have a particular effect on e.g. the
human circadian rhythm - linked to various diseases
including some cancers, diabetes and depression.
There is growing interest in using colour-related
methods as way to alleviate problems caused by
anxiety, depression and degenerative conditions such
as Dementia as a more sustainable treatment path
when compared with drug prescription. The effects
of using CBRT™, with any resulting neuroplasticity
(and neuropharmacology ‘pre and post treatment’
requirements) are potential areas of future CBRT™
research interest with partners in bioscience and
neuroscience.
WHAT IS CBRT™?
CBRT™ is a suitable training programme and
intervention for many different levels of professionals
working within nursing, allied healthcare, education,
social care, counselling CAM, yoga and sports
motivation.
The two day CBRT™ Practitioner Training Programme
currently requires the post training completion of
40 question assessment paper and 10 case studies.
CBRT™ Practitioners are trained to deliver a quality
structured 45 minutes relaxation support session
experience, suitable for both 1 to 1 (Practitioner and
individual session) and group settings of up to 20
people. The CBRT™ Practitioners trained during the
R & D stages often work within mental health, social
care and education in their communities.
Dr. K T Birinder trained in 2005, is an NHS GP who uses
CBRT™ with her Patients in her Barnsley GP Practice.
OTHER DRIVERS: COMPLEMENTARY HEALTH IS OFTEN
NOT ‘REGULATED ENOUGH’ TO PROVIDE A MORE HOLISTIC
CHOICE AND SOLUTIONS IN CLINICAL SETTINGS.
Regulation is an area CBRT™ intends to take the lead.
The Colour Breathing Apparatus and Practitioner
Training Programme is being prepared for Quality
Management Systems ISO: 13485 (Class 1 Medical
Device); CE mark for EU healthcare sector, FDA
(USA compliance registration) and CPD Training
Accreditation with The Royal College of Nursing
and other key training organisations. In 2004,
Colour Breathing was accepted by the BCMA (British
Complementary Medicine Association) as a relaxation
technique and training programme. The CBRT™
Practitioner Code of Conduct came into effect and is
based on the UK midwifery code.
CBRT™ SUPPORTS INTEGRATED CARE AND IS A BRIDGE
BETWEEN CAM AND TRADITIONAL PSYCHIATRIC THERAPIES
An easy to learn technique, CBRT™ has the potential
to deliver measurable outcomes as part of clinician
led mental health and wellbeing programmes. More
importantly - it is a straightforward, easy to use, low
cost psychological therapy which people appear to
enjoy using.
THE NHS AND GOVERNMENT MUST SUPPORT PRIVATE
HEALTHCARE INNOVATION SEEKING PILOTS FOR EVIDENCE
The CBRT™ focus has always been to train nursing,
allied healthcare staff and healthcare assistants in
the CBRT™ technique so they can deliver CBRT™
Relaxation Support Sessions for NHS patients and
create NHS evidence.
Colour Breathing has bootstrapped all costs of
concept , research and development since 1997
including 3 years participation in a national schools
programme for EI (emotional intelligence) skills called
the “Discovery Programme” based in Portsmouth.
The children responded very well to using Colour
Breathing as a technique for both relaxation,
concentration and focus skills. Colour Breathing also
became part of community based mental health &
wellbeing programmes in Belfast and Northern Ireland
(2005 to present) training groups of Colour Breathing
Practitioners with one of the largest charities “Action
Mental Health” and “NHS Southern Health Care
Foundation Trust.”
In 2009, a SEHTA (South East Health Technology
Alliance) Consultant suggested Colour Breathing focus
on serving the ‘home healthcare market sector’ first,
through NHS entry and create the acronym “CBRT™.”
Since 2010, CBRT™ has prepared for NHS entry and
selected by the Department of Health Innovation
Policy Team , showcased at the very first 2011
Healthcare Innovation Expo. This was followed by
national meetings with NHS Directorate, clinicians
and NHS NIHR research teams - all trying to help
find suitable funding pathways to create NHS clinical
evidence. An NHS NIHR Manager suggested a budget
of at least £20 million would be required for the
NHS to create a similar new psychological therapy
intervention.
Over 18 months, three detailed CBRT™ NHS QIPP
Initiatives were written as this was felt to be the way
forwards and to seek central funding for the pilots.
These were supported by senior management
within the NHS and DH Innovation Policy Team.

3. 5 0 | I N N O VAT I O N T O D AY
QIPP National guidelines were included to create
cost savings whilst improving quality improvement,
productivity and prevention in mental health provision
for NHS patients. The three initiatives were written to
create NHS evidence for three key groups of patients:
those who experience anxiety and depression, children
and young people, older people and dementia.
In 2012 CBRT™ was introduced to the DH Innovation
Commercial Procurement Team. CBRT™ completed
the NHS NIC (National Innovation Centre) Technology
Scorecard Process (92.53% score) as a medical device
(technology) and psychological therapy system -
taking four months to complete. The Colour Breathing
products and Practitioner Training Programme were
included in the review. The initiatives were also verified
by other senior NHS Management . Yet despite these
outcomes there was no suitable NIC funding for the
initiatives!
A Senior NHS Psychological Therapies
Commissioning Manager who reviewed the initiatives
wrote :
“The principles of building confidence and
socialisation are good, as commissioners we
understand how important this is for a patient’s
recovery. The proposal is very good and well
presented, with a good evidence base and clinical
outcomes. On paper, the savings are good, a
reduction in primary care presentations, and this
is similar to IAPT where we also know there are
reductions in referrals to secondary care.”
For five years, CBRT™ was totally stuck in a ‘chicken
and egg situation’ as it was impossible to raise any
bank funding to action the NHS pilots and the many
letters to different NHS organisations requesting
funding support were often ‘lost in the system.’ Our
local MP wrote to the Prime Minister David Cameron
and Chairman and Chief Executive of NHS England
about the situation asking to support CBRT™ as a small
healthcare innovation company. There has always
been a strong grassroots support for the CBRT™
initiatives - for if you don’t get to pilot something new
- how will you ever find out if it actually helps patients?
In 2013, the NHS England National Director of the IAPT
(Improving Access to Psychological Therapy) Adult
Programmes suggested CBRT™ write to The Secretary
of State for health and include that “CBRT™ is a policy
matter of national interest.”
The Secretary of State wrote to suggest that
CBRT™ apply for a grant with the £5 million RIF
Fund (Regional Innovation Fund) and CBRT™ duly
submitted 3 applications, one for each initiative - each
headed up with a Chief Executive of an NHS Clinical
Commissioning Group as named ‘clinical lead.’
Many were stunned when nothing became of any of
the applications. The deadline dates also changed
so the £5million innovation money awarded in the
January had to be used by 31 March the same year.
CBRT™ was then advised to apply for the next
£2.5 million RIF Fund but the criteria had changed and
the 3 applications had to be re-written to a maximum
£200,000 grant per project. It was then discovered that
the criteria had been reverted to a maximum £250,000
grant per project and the deadline dates changed
again. It was a chaotic process and CBRT™ had to write
to ask what had become of our applications - one
application we still don’t know the outcome!
The CBRT™ initiatives can now finally become
actioned with investment. These might happen in the
NHS but we can now look to run pilot programmes in
the USA, Middle East and Australia. It is still very hard to
understand why in the 5 years of preparation for NHS
entry that no funding could be found - only that the
NHS is a closed shop. A senior NHS England clinician
did advise me that “In normal circumstances... this
type of innovation only happens with clinicians and
front line staff”.
Five months of independent NHS due diligence
by ‘NHS South of England’ not only supported and
recommended the piloting of CBRT™ as an innovation
but also aligned the potential NHS patient benefits
with the NICE Quality Standards for depression.
It confirmed that the initiatives could potentially
help many thousands of patients learn how to relax
naturally and perhaps prevent them from having to be
given medication and save the NHS more than
£18 million per year.
CBRT™ was also selected for poster presentation by
an independent BMJ and NHS England panel for the
2013 “Future of Health Conference” for Long Term
Conditions.
LONE INVENTORS - NEED FAR MORE ££ SUPPORT FROM
THE UK GOVERNMENT AND UNDERSTANDING FROM HIGH
STREET BANKS
There is an unsaid presumption in healthcare
invention that a scientist or clinician will always invent
something superior to the unknown lone inventor. Yet
some of the very best inventions were created by ‘lone
inventors’ such as Charles Goodyear, Thomas Edison,
Alexander Graham Bell, etc. Life experiences can
contribute to innovation.
The UK Government supports mostly start-up
companies and those achieving substantial turnover.
I N N O VAT I O N T O D AY | 5 1
Many grants are for use in collaboration with
universities - who already have their own innovation
agenda and are public funded.
Until there is real thirst for culture change and
genuine understanding of the actual difficulties
involved in private innovation - small UK innovation
will continue to suffer - mainly through lack of
investment.
LONE INVENTORS NEED IP AND LEGAL SUPPORT WHEN
THEIR RIGHTS ARE EXPLOITED. THE UK INTELLECTUAL
OFFICE NEEDS TO PROVIDE SOME PRACTICAL SUPPORT IN
THE FORM OF SOME IPR INSURANCE COVER. THIS COULD
BE INCLUDED IN THE ANNUAL COST OF THE PATENT FEES
This is written from a real and costly experience.
In 2003, a major challenge happened to Colour
Breathing at the Frankfurt Book Fair. At this stage,
Colour Breathing was in the final stages of finalising
the first co-edition contract for publication rights in the
USA when a Korean publishing house “Healing Society”
had copied my work. The previous year - Hye Seon
Kim, chief director Healing Society - had requested a
Colour Breathing kit be sent and to include a co-edition
contract for these. A FedEx receipt provided signed
proof of receipt. Despite Colour Breathing having full
copyright and registered Patent , Dr. Ilchi Lee (leader
of Dhan Yoga movement in Sedona) claimed full
copyright on his version of my work of then 6 years
- naming it “Healing Chakra.” A multimillionaire, his
version launched (albeit in poor quality print editions)
with a 17 state USA tour to his “followers.”
Our first co edition contract (worth an initial £135,000)
had to be cancelled due to legal action Legal costs for
the next 3 years ran into thousands of pounds and as
I had just had a child we did not have the £200,000
minimum legal purse required to take him to court
in Arizona. It was estimated that a minimum £1.5
million pounds profits were made in Year One sales of
“Healing Chakra” in the USA alone, not including other
related activities or language editions.
Just imagine - losing a contract which is ready to sign,
then the anticipated income from forecasted future
sales (£1.635 million) then also having to fund legal
costs. There was no support available from the UK
Government (IP Office) or our business bank (RBS) If
there had been some form of ‘mechanism’ to support
the company to take legal action- there is an excellent
chance that some of the initial losses could have
been recovered. Our case was deemed ‘strong’ due
to factual printed evidence. (Nobody can even guess
what the long term company losses could amount to.)
Media attention suggests the UK government
supports entrepreneurs and female innovators yet the
reality is - there is no support from UK Banks. When
starting the concept stage of Colour Breathing - our
Bank ‘then’ - ‘RBS’ - would not consider any form of
long term ‘R & D’ loan. So due to the size of the project
finance requirement, we were left with no option
but to mortgage and re-mortgage our home - many
times - with any profits made having to go straight
back into the R & D process. Just think how innovation
could be transformed if UK Banks started to support
inventors and allow their IPR (valued by specialists) for
collateral use against a long term government backed
loan? Why not? How much government money is
wasted each year in abandoned public technology or
health research programmes? The public sector and
pharmaceutical industries dominate innovation and
research funding. CBRT™ has yet to meet any other
healthcare inventors who have been made to face
quite so many challenges.
CHANGE IS FINALLY ‘ON THE CARDS’ FOR CBRT™ - THANKS
TO THIS £10 MILLION GLOBAL INVESTMENT PROGRAMME
OPPORTUNITY
Investors interested in helping to make a real
difference in the world of mental health please contact
Alison Bourne. CBRT™ has over 60 new consumer-
friendly products to launch, many suggested by
mental health professionals. CBRT™ strategy includes
collaboration through international brand licence
agreements and alliances to complete a wide interest
Colour Breathing product range for global markets.
With growing consumer interest in yoga, mindfulness,
self- help tools and training programs in many
territories, CBRT™ will initially launch in the USA ,
Canada, UK, Ireland, Australia, New Zealand and The
Middle East. CBRT™ will have its own research teams
for new patent applications and exciting research
programs. The CBRT™ Advisory Board is currently
being formed.
C
BRT™ is working to improve
mental health outcomes
for individuals, families, and
communities.
To become part of this global reaching healthcare
investment opportunity contact : Alison Bourne,
Director CBRT Healthcare Innovation Systems Ltd
E: invest@colourbreathing.com | T: 01425 629602